Home › Free Stock Grades › SEPN
Septerna Inc (SEPN) Stock Grade
SEPN · Healthcare
A+
Market Cap
$1.2B
P/E Ratio
—
Revenue Growth (YoY)
+4174.5%
Net Margin
-106.4%
Return on Equity
—
Dividend Yield
None
About Septerna Inc's fundamentals
Septerna Inc is a biotechnology company with a market capitalization of $1.2 billion that reported exceptional revenue growth of 4,174.5% year-over-year, indicating rapid commercialization or scale-up of its business. However, the company is currently unprofitable, with a net margin of -106.4%, meaning it lost $1.06 for every dollar of revenue generated in its latest annual period. Despite the accounting losses, Septerna generated positive free cash flow, suggesting that while the company is not yet profitable, its operations are producing cash. The company does not pay a dividend.